Wells Fargo’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.5M Buy
364,205
+108,520
+42% +$4.75M ﹤0.01% 1612
2025
Q4
$9.88M Buy
255,685
+35,422
+16% +$1.35M ﹤0.01% 2054
2025
Q3
$7.77M Buy
220,263
+144,475
+191% +$5.23M ﹤0.01% 2205
2025
Q2
$2.73M Sell
75,788
-8,486
-10% -$281K ﹤0.01% 2956
2025
Q1
$2.62M Buy
84,274
+14,154
+20% +$449K ﹤0.01% 2948
2024
Q4
$1.79M Buy
70,120
+15,790
+29% +$419K ﹤0.01% 3275
2024
Q3
$1.54M Buy
54,330
+6,174
+13% +$171K ﹤0.01% 3245
2024
Q2
$1.27M Sell
48,156
-2,189
-4% -$60.7K ﹤0.01% 3331
2024
Q1
$1.53M Buy
50,345
+35,453
+238% +$1.05M ﹤0.01% 3175
2023
Q4
$418K Buy
14,892
+311
+2% +$8.55K ﹤0.01% 3979
2023
Q3
$396K Sell
14,581
-28,820
-66% -$856K ﹤0.01% 3925
2023
Q2
$1.33M Buy
43,401
+8,202
+23% +$278K ﹤0.01% 3229
2023
Q1
$1.27M Buy
35,199
+12,571
+56% +$466K ﹤0.01% 3212
2022
Q4
$894K Sell
22,628
-16,170
-42% -$675K ﹤0.01% 3310
2022
Q3
$1.56M Buy
38,798
+3,642
+10% +$156K ﹤0.01% 2917
2022
Q2
$1.48M Buy
35,156
+7,547
+27% +$309K ﹤0.01% 3024
2022
Q1
$1.08M Buy
27,609
+3,543
+15% +$139K ﹤0.01% 3827
2021
Q4
$959K Sell
24,066
-32,848
-58% -$1.28M ﹤0.01% 4146
2021
Q3
$2.06M Sell
56,914
-49,210
-46% -$1.91M ﹤0.01% 3651
2021
Q2
$4.35M Buy
106,124
+70,277
+196% +$2.99M ﹤0.01% 2985
2021
Q1
$1.56M Sell
35,847
-350,796
-91% -$16.6M ﹤0.01% 3914
2020
Q4
$19.4M Buy
386,643
+357,244
+1,215% +$15.2M ﹤0.01% 1586
2020
Q3
$1.24M Sell
29,399
-336,931
-92% -$14.5M ﹤0.01% 3687
2020
Q2
$17.8M Buy
+366,330
New +$18.1M 0.01% 1442

Other funds holding RPRX